Pharmafile Logo
Pharmafocus logo
Advanced Search

Corporate

Showing 6 posts of 111 posts found.

Steriline’s founder “passes torch” to children with CEO and CSO appointments

September 19, 2024
Corporate, Steriline

Aseptic packaging company Steriline’s founder Gerardo Fumagalli has “passed the torch” to his children Illaria Fumagalli and Federico Fumagalli, who …

Appointment

Leadership Appointments at RQM+

August 28, 2024
Research and Development AI and ML, Corporate, RQM+, appointment

Ronnie Mahofski and Kevin Rowland both become Executive Vice President and General Manager On August 27, MedTech service provider RQM+ announced …

Appointment

David Wheadon appointed to board of directors at Seaport Therapeutics

August 14, 2024
Corporate, Seaport Therapeutics, appointment

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

News
acute_leukemia-all

Merck to acquire Curon Biopharmaceutical’s B-Cell Depletion Therapy

August 12, 2024
Research and Development Corporate, Curon Biopharmaceuticals, Merck, Oncology, b-cells

Merck have announced that they have entered into an agreement with private biotechnology company Curon Biopharmaceuticals to acquire CN201, a …

News

Richmond promotes new Director of Communications and Participant Engagement

August 9, 2024
Research and Development Corporate, Richmond Pharmacology, appointment, pharmaceutical

Richmond Pharmacology is delighted to announce the promotion of Liz Romano to the new position of Director of Communications and …

Appointment

Cresset collaborates with global leaders Enamine to enable the design of new Targeted Protein Degraders 

August 9, 2024
Research and Development Corporate, Cresset, Cressete, Enamine, Microbiology, Targeted Protein Degraders

This week, drug discovery company Cresset has announced the extension of its global collaboration with chemical and biological contract research …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026